Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of General and Family Medicine|December 22, 2017
Cluster analysis of pharmacists' work attitudesKeiichi Nakagomi, Yukikazu Hayashi, Takako KomiyamaBiological & Pharmaceutical Bulletin|April 5, 2016
Rapidity and Severity of Hemoglobin Decreasing Associated with Erythrocyte Inosine Triphosphatase Activity and ATP Concentration during Chronic Hepatitis C TreatmentYoichi Tanaka, Yumi Tamura, Hiroaki Yokomori, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Differential induction of serum interleukin-6 and -12 by interferon-alpha and -beta administration in chronic hepatitis C patientsMiyoshi Kido, Naoki Kumagai, Kyoko Toda, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 6, 2005
Collection of medical drug information in pharmacies: Drug Event Monitoring (DEM) in JapanSei-ichiro Hayashi, Akira Nanaumi, Yasuji Akiba, et al.Current Therapeutic Research, Clinical and Experimental|April 3, 2014
Pharmacokinetics and postoperative analgesia of epidural tramadol: A prospective, pilot studyRie Kubota, Takako Komiyama, Yasuko Miwa, et al.Therapeutic Drug Monitoring|March 1, 2019
Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA GenotypeYoichi Tanaka, Akiko Inoue, Tomohiko Mizunuma, et al.Leukemia & Lymphoma|July 20, 2013
Methylenetetrahydrofolate reductase gene haplotypes affect toxicity during maintenance therapy for childhood acute lymphoblastic leukemia in Japanese patientsYoichi Tanaka, Atsushi Manabe, Hisaya Nakadate, et al.Pharmacy (Basel, Switzerland)|June 3, 2018
Clinical Pharmacy Education in Japan: Using Simulated Patients in Laboratory-Based Communication-Skills Training before Clinical PracticeRie Kubota, Kiyoshi Shibuya, Yoichi Tanaka, et al.Hepato-Gastroenterology|November 21, 2007
Clinical application of the leukocyte migration test and new diagnostic criteria for identifying causative agents in patients with drug-induced liver injuryKensuke Usui, Yoshisada Oda, Rie Kubota, et al.Hepatitis Research and Treatment|December 15, 2010
Optimal erythrocyte ribavirin level to reduce the risk of anemia and obtain an early virological response in patients with chronic hepatitis C caused by genotype 1b infectionRie Kubota, Takako Komiyama, Naoki Kumagai, et al.Pageof 2